anidulafungin has been researched along with P carinii Pneumonia in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (14.29) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 4 (57.14) | 24.3611 |
2020's | 2 (28.57) | 2.80 |
Authors | Studies |
---|---|
Ashbaugh, A; Cushion, MT; Hauser, PM; Mosley, C; Sayson, SG | 1 |
Adeojo, LW; Alfaro, R; Ashbaugh, A; Cushion, MT; Kovacs, JA; Kumar, P; Lu, R; Mannino, R; Tramont, E | 1 |
Ashbaugh, A; Cushion, MT; Hendrix, K; Linke, MJ; Porollo, A; Sayson, SG; Tisdale, N | 1 |
Damiani, C; Le Gal, S; Nevez, G; Totet, A | 1 |
Chang, HC; Chen, TC; Yang, WT | 1 |
Ashbaugh, A; Collins, MS; Cushion, MT; Linke, MJ; Lynch, K | 1 |
Bartlett, MS; Boylan, CJ; Current, WL; Goheen, MP; Lee, CH; Queener, SF; Shaw, MM; Smith, JW | 1 |
7 other study(ies) available for anidulafungin and P carinii Pneumonia
Article | Year |
---|---|
Anidulafungin Treatment Blocks the Sexual Cycle of Pneumocystis murina and Prevents Growth and Survival without Rescue by an Alternative Mode of Replication.
Topics: Anidulafungin; Animals; Echinocandins; Ecosystem; Pneumocystis; Pneumonia, Pneumocystis | 2022 |
A Novel Encochleated Formulation Improves Atovaquone Activity in a Murine Model of Pneumocystis Pneumonia.
Topics: Anidulafungin; Animals; Antifungal Agents; Atovaquone; Disease Models, Animal; Mice; Pneumonia, Pneumocystis | 2021 |
Gene Expression of Pneumocystis murina after Treatment with Anidulafungin Results in Strong Signals for Sexual Reproduction, Cell Wall Integrity, and Cell Cycle Arrest, Indicating a Requirement for Ascus Formation for Proliferation.
Topics: Anidulafungin; Animals; Antifungal Agents; Cell Cycle Checkpoints; Cell Proliferation; Cell Wall; Male; Mice; Pneumocystis; Pneumonia, Pneumocystis | 2018 |
The Fascinating Echinocandin-Treated Mouse Model of Pneumocystis murina To Understand Pneumocystis jirovecii.
Topics: Anidulafungin; Animals; Cell Cycle Checkpoints; Cell Proliferation; Cell Wall; Echinocandins; Mice; Pneumocystis; Pneumocystis carinii; Pneumonia, Pneumocystis | 2018 |
Pneumocystis jirovecii pneumonia in a human immunodeficiency virus-infected patient with G6PD deficiency-successful treatment with anidulafungin.
Topics: AIDS-Related Opportunistic Infections; Anidulafungin; Antifungal Agents; Antiretroviral Therapy, Highly Active; Glucosephosphate Dehydrogenase Deficiency; HIV Infections; Humans; Immunocompromised Host; Male; Pneumonia, Pneumocystis; Treatment Outcome; Young Adult | 2018 |
Characterization of a distinct host response profile to Pneumocystis murina asci during clearance of pneumocystis pneumonia.
Topics: Albumins; Anidulafungin; Animals; Antifungal Agents; Bronchoalveolar Lavage Fluid; Cell Wall; Echinocandins; Female; Flow Cytometry; Inflammation; Lung; Mice; Mice, Inbred C3H; Pneumocystis; Pneumonia, Pneumocystis | 2013 |
Semisynthetic echinocandins affect cell wall deposition of Pneumocystis carinii in vitro and in vivo.
Topics: Anidulafungin; Animals; Antifungal Agents; Cell Line; Cell Wall; Dexamethasone; Echinocandins; Humans; Immunocompromised Host; Immunosuppressive Agents; Lung; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Microscopy, Electron; Peptides, Cyclic; Pneumocystis; Pneumonia, Pneumocystis; Rats | 1996 |